Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

about

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

Item

http://www.wikidata.org/entity/Q42656566

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

@en

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

@nl

type

Item

label

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

@en

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

@nl

prefLabel

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

@en

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

@nl

P1476

Diabetic osteoarthropathy care in Sweden - Need for improvement: A national inventory

@en

P2093

Börje Åkerlund

http://www.w3.org/2001/XMLSchema#string

Kurt Gerok-Andersson

http://www.w3.org/2001/XMLSchema#string

Linda Wennberg

http://www.w3.org/2001/XMLSchema#string

Paul Lundgren

http://www.w3.org/2001/XMLSchema#string

Peter Aspelin

http://www.w3.org/2001/XMLSchema#string

Rimma Axelsson

http://www.w3.org/2001/XMLSchema#string

P2860

The Charcot foot in diabetes

Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.

Charcot neuroarthropathy in diabetes mellitus.

Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.

High levels of anxiety and depression in diabetic patients with Charcot foot.

Physician knowledge of a rare foot condition - influence of diabetic patient population on self-described knowledge and treatment.

Current concepts of Charcot foot in diabetic patients.

The impact of comorbidities on inpatient Charcot neuroarthropathy cost and utilization.

Conservative and Pharmacologic Treatments for the Diabetic Charcot Foot.

F-18 FDG PET/CT scanning in Charcot disease: a brief report.

P304

32-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCTE.2017.06.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29067267

http://www.w3.org/2001/XMLSchema#string

P932

5651304

http://www.w3.org/2001/XMLSchema#string